ADARx Pharmaceuticals ADRX has just completed a US 446.25 million IPO at US 17 per share, placing the RNA-focused biotech at roughly US 2.1 billion in market value. The first sessions post listing have been active for AD
Why Is ADRX (ADRX) Stock Down Today?
Updated Nov 16, 2026 7:30 PM ET · Prev Close $14.20
Primary Move Catalyst & Conviction
50% Signal ConvictionADRX showing strong bearish momentum
ADRX is down 2.4% today on 0.6x average volume. The move appears to be driven by general market sentiment and momentum traders.
Market & Sector Relative Strength
ADRX trading in line with the S&P 500 (+0.50% alpha)Recent ADRX Catalyst Headlines
Verified WireCompleted initial public offering IPO and concurrent private placement generating aggregate gross proceeds of approximately 602.5 million cash position expected to fund operations into 2030 Advanced three Phase 2 clinica
San Diego, Nov. 09, 2026 Globe Newswire -- Adarx Pharmaceuticals, Inc. Nasdaq ADRX , a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, today announced that Zhen Li, Ph.D., Preside
San Diego, Oct. 01, 2026 Globe Newswire -- Adarx Pharmaceuticals, Inc. ADARx Nasdaq ADRX , a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today that, in connection wi
1–3 Day Expected Range & Key Level
45% Follow-ThroughWatch for breakdown below $13.87
1-Year Historical Move Analogs
9 EventsSessions in the past year where ADRX moved >3.0% down:
About ADRX
Get Instant ADRX Catalyst Alerts
Receive an email alert when ADRX triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversADRX Session & Catalyst FAQ
Why is ADRX stock down today?
ADRX is down 2.4% today on 0.6x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is ADRX stock a buy or sell right now?
Today's session carries a 50% catalyst conviction score on 0.60x relative volume (low participation). Our multi-factor model currently rates ADRX as HOLD. Review full valuation, quality, and timing signals on the ADRX Buy or Sell Decision Brief →
What is ADRX's intrinsic value and expected trading range?
At $14.00, ADRX's modeled 1-to-3 session range is $13.45 – $14.14, with a key inflection level at $13.17 (support). Compare current price against multi-year cash flow projections in the ADRX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.